Comparing SOC Telemed (TLMD) and Its Competitors

SOC Telemed (NASDAQ: TLMD) is one of 27 publicly-traded companies in the “Miscellaneous health & allied services, not elsewhere classified” industry, but how does it contrast to its peers? We will compare SOC Telemed to similar companies based on the strength of its profitability, dividends, risk, valuation, earnings, institutional ownership and analyst recommendations.

Analyst Ratings

This is a summary of recent ratings and recommmendations for SOC Telemed and its peers, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SOC Telemed 0 1 5 0 2.83
SOC Telemed Competitors 92 389 536 15 2.46

SOC Telemed currently has a consensus price target of $10.50, suggesting a potential upside of 73.27%. As a group, “Miscellaneous health & allied services, not elsewhere classified” companies have a potential upside of 8.54%. Given SOC Telemed’s stronger consensus rating and higher probable upside, equities research analysts clearly believe SOC Telemed is more favorable than its peers.

Profitability

This table compares SOC Telemed and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
SOC Telemed N/A -96.38% -23.51%
SOC Telemed Competitors -39.15% 16.05% -9.95%

Earnings & Valuation

This table compares SOC Telemed and its peers top-line revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
SOC Telemed $57.99 million -$49.85 million -1.71
SOC Telemed Competitors $1.94 billion $96.17 million 42.17

SOC Telemed’s peers have higher revenue and earnings than SOC Telemed. SOC Telemed is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Volatility & Risk

SOC Telemed has a beta of 0.04, suggesting that its stock price is 96% less volatile than the S&P 500. Comparatively, SOC Telemed’s peers have a beta of 7.07, suggesting that their average stock price is 607% more volatile than the S&P 500.

Insider & Institutional Ownership

74.6% of SOC Telemed shares are held by institutional investors. Comparatively, 43.2% of shares of all “Miscellaneous health & allied services, not elsewhere classified” companies are held by institutional investors. 6.9% of SOC Telemed shares are held by company insiders. Comparatively, 26.4% of shares of all “Miscellaneous health & allied services, not elsewhere classified” companies are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

SOC Telemed peers beat SOC Telemed on 8 of the 13 factors compared.

About SOC Telemed

SOC Telemed, Inc. provides acute care telemedicine services and technology to hospitals, health systems, physician groups, and government organizations in the United States. The company's technology platform, Telemed IQ, provides telemedicine programs. Its telemedicine solutions include teleNeurology, telePulmonology, telePsychiatry, and teleICU. The company was founded in 2004 and is based in Reston, Virginia.

Receive News & Ratings for SOC Telemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SOC Telemed and related companies with MarketBeat.com's FREE daily email newsletter.